Dr. Lal PathLabs LimitedNSE: LALPATHLAB

Press Release Oct 31 2025

· Issued by Dr. Lal PathLabs Limited

Filed with NSE · · 3 pages · English

Summary by 6ix AI

The company reported a revenue increase compared to the same period last year, along with growth in EBITDA and profit after tax. Additionally, an interim dividend has been declared and a bonus issue has been approved by the board.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Dr. Lal PathLabs Limited on 6ix

Earlier from Dr. Lal PathLabs

Later from Dr. Lal PathLabs

All Dr. Lal PathLabs news releases